Save 35% + Free Shipping — Single Vials In Stock · code

Back to Catalog

Peptides

GHK-Cu 100 mg

$133Per Unit

Pharmaceutical-grade copper peptide with full analytical panel and institutional documentation support.

Lot GHK2025-05B · COA on request
Lyophilized peptide complex
2–8°C

5 × $133.00 = $665.00 $432.25 (35% off with code EHAB35 + free shipping)

Your order of 5 units qualifies: apply code EHAB35 at checkout for 35% off and free shipping.

GHK-Cu 100 mg

$432.25 for 5 · 35% off

Research use only
GHK-Cu 100 mg research packaging
Lyophilized peptide complex
Anubis Research Labs

Documentation

The certificate of analysis for the current lot (Lot GHK2025-05B) is sent on request, so you can review identity and purity testing before you order.

Request the lot COA

Research summary

GHK-Cu(Copper tripeptide-1, glycyl-L-histidyl-L-lysine copper)

Regulatory status
Not an approved drug. Used in topical cosmetics; FDA lists injectable GHK-Cu among substances that may present significant safety risks in compounding.
Strongest evidence
Cell and gene-expression studies; small topical cosmetic studies in people
Overview

GHK is a naturally occurring tripeptide that binds copper. The copper complex, GHK-Cu, is a common cosmetic ingredient and a research subject in skin and tissue biology.

What researchers study it for
  • Skin remodeling and wrinkle appearance (topical)
  • Wound healing models
  • Gene-expression effects in cell data
Mechanism

In laboratory data GHK-Cu influences collagen synthesis, antioxidant responses and the expression of many genes; how much of this occurs in living tissue is uncertain.

Evidence (3)
  1. Review

    Gene-data review (Int J Mol Sci, 2018)

    Summarizes regenerative and protective actions reported for GHK-Cu, much of it from cell and gene-expression datasets.[1]

  2. Review

    Topical anti-wrinkle review (Bioimpacts, 2025)

    Reviews topical GHK as an anti-wrinkle peptide, including its advantages and formulation problems.[2]

  3. Regulatory

    FDA compounding risk list

    Injectable GHK-Cu is listed; FDA notes limited human data for injectable routes.[3]

Limitations of the evidence
  • Human evidence is topical and cosmetic; injectable human data are scarce.
  • Products on this site are sold for laboratory research only. They are not the medicines used in the trials above, and those results do not apply to research material.
Sources (3)
  1. 1.Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene DataPickart L, Margolina A. Int J Mol Sci. 2018 Review
  2. 2.Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospectiveMortazavi SM et al. Bioimpacts. 2025 Review
  3. 3.Certain bulk drug substances for use in compounding that may present significant safety risks (lists GHK-Cu for injectable routes)U.S. FDA, page current as of Apr 22, 2026 Regulatory
Every published studyPubMed search: GHK-Cu(opens in a new tab)Every registered trialClinicalTrials.gov search: GHK-Cu(opens in a new tab)

Reviewed 2026-10-02. Summaries describe published research and regulatory records; they are not medical advice and do not describe how to use this product. Sold for laboratory research use only.